First emergence of pyoderma gangraenosum, palmoplantar pustulosis and sacroiliitis in a psoriasis patient associated with switching from secukinumab to brodalumab

J Eur Acad Dermatol Venereol. 2019 Nov;33(11):e406-e407. doi: 10.1111/jdv.15714. Epub 2019 Jun 13.

Authors

C D Sadik¹, M Thieme¹, D Zillikens¹, P Terheyden¹

Affiliation

¹ Department of Dermatology, Allergy, and Venereology, University of Lübeck, Lübeck, Germany.

PMID: 31131924
DOI: 10.1111/jdv.15714

No abstract available

Publication types

Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use*
Dermatologic Agents / adverse effects
Dermatologic Agents / therapeutic use*
Female
Humans
Psoriasis / complications
Psoriasis / drug therapy*
Pyoderma Gangrenosum / chemically induced*
Sacroiliitis / chemically induced*

Substances

Antibodies, Monoclonal, Humanized
Dermatologic Agents
brodalumab
secukinumab